Article
Variability of in vivo recovery of factor IX after infusion of monoclonal antibody purified factor IX concentrates in patients with hemophilia B. The Mononine Study Group.
Thrombosis and haemostasis - 1 May 1995
White G C, Shapiro A D, Kurczynski E M, Kim H C, Bergman G E
Abstract excerpt
Monoclonal antibody purified factor IX concentrate, Mononine (Armour Pharmaceutical Company, Kankakee, Illinois, USA), is a recently developed replacement factor concentrate for the treatment of patients with hemophilia B. The pharmacokinetic properties of monoclonal antibody purified factor IX c...
Topics
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal
- Body Weight
- Child
- Child, Preschool
- Chromatography, Affinity
- Factor IX
- Female
- Genetic Variation
- Hemophilia B
- Hemorrhage
- Humans
- Immunosorbent Techniques
- Infant
- Infusions, Intravenous